Sign In
Buy AVXL
$2.65
-0.140 (-5.03%)
At Close: Jun 03, 2026
AVXL Stock Price: Over 9% Increase Details
09:35am, Monday, 14'th Jun 2021
The stock price of Anavex Life Sciences Corp (NASDAQ: AVXL) increased by over 9% during intraday trading. These are the details.
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
Anavex Life Sciences (AVXL) Just Reclaimed the 50-Day Moving Average
09:01am, Thursday, 03'rd Jun 2021
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising Investment
10:27am, Wednesday, 02'nd Jun 2021
Healthcare faces an important decision as the Supreme Court decides on the Affordable Care Act. Biotechs face an important FDA decision on approval of an Alzheimer's treatment.
Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q2 2021 Results - Earnings Call Transcript
11:25pm, Thursday, 13'th May 2021
Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q2 2021 Results - Earnings Call Transcript
Why Anavex Life Sciences (AVXL) Might Surprise This Earnings Season
09:46am, Tuesday, 11'th May 2021
Anavex Life Sciences (AVXL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Anavex Life Sciences to Present at the B. Riley Securities' Virtual Neuroscience Conference
07:00am, Monday, 26'th Apr 2021
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
3 Biotech Neurology Stocks Pursuing Alzheimer's And Parkinson's Diseases
08:00am, Friday, 16'th Apr 2021
3 Biotech Neurology Stocks Pursuing Alzheimer's And Parkinson's Diseases
Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference
07:00am, Thursday, 08'th Apr 2021
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Anavex Life Sciences Announces Participation at Upcoming World EPA - Evidence, Pricing and Access - Congress 2021
07:00am, Wednesday, 07'th Apr 2021
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Anavex: Small Company Targeting The Holy Grail Of Medicine
05:06pm, Tuesday, 06'th Apr 2021
Anavex is targeting Alzheimer's disease and other neurodegenerative diseases. It recently announced positive data from two of its programs.
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Anavex And Cassava Sciences: Closer To An Understanding Of Alzheimer's Disease
04:31pm, Tuesday, 23'rd Mar 2021
Cassava Sciences simufilam produced an improvement in ADAS-cog scores of 1.6 points at 6 months.
Anavex Life Sciences to Present at the H.C. Wainwright Global Life Sciences Conference
07:00am, Thursday, 04'th Mar 2021
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Top Wall Street analysts say buy stocks like Denny's and Cloudflare as economy reopens
08:12am, Sunday, 21'st Feb 2021
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Shopify & GoDaddy
